• English
    • português
    • español
  • Ir al sitio de CLACAI
  • English 
    • English
    • português
    • español
  • Login
View Item 
  •   DSpace Home
  • Materiales Informativos
  • Artículos
  • View Item
  •   DSpace Home
  • Materiales Informativos
  • Artículos
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Women’s experiences with the use of medical abortion in a legally restricted context: the case of Argentina

Thumbnail
View/Open
RHM43S-786-Ramos.pdf (330.2Kb)
Date
2014
Author(s)
Ramos, Silvina
Romero, Mariana
Aizenberg, Lila
Metadata
Show full item record
Abstract
This article presents the findings of a qualitative study exploring the experiences of women living in Buenos Aires Metropolitan Area, Argentina, with the use of misoprostol for inducing an abortion. We asked women about the range of decisions they had to make, their emotions, the physical experience, strategies they needed to use, including seeking health care advice and in dealing with a clandestine medical abortion, and their overall evaluation of the experience. An in-depth interview schedule was used. The women had either used misoprostol and sought counselling or care at a public hospital (n=24) or had used misoprostol based on the advice of a local hotline, information from the internet or from other women (n=21). Four stages in the women’s experiences were identified: how the decision to terminate the pregnancy was taken, how the medication was obtained, how the tablets were used, and reflections on the outcome whether or not they sought medical advice. Safety and privacy were key in deciding to use medical abortion. Access to the medication was the main obstacle, requiring a prescription or a friendly drugstore. Correct information about the number of pills to use and dosage intervals was the least easy to obtain and caused concerns. The possibility of choosing a time of privacy and having the company of a close one was highlighted as a unique advantage of medical abortion. Efforts to improve abortion law, policy and service provision in Argentina in order to ensure the best possible conditions for use of medical abortion by women should be redoubled.
URI
http://clacaidigital.info/handle/123456789/631
Collections
  • Artículos [158]
  • Artículos académicos [299]
  • 2. América Latina y el Caribe [894]
  • Argentina [338]
  • Aborto autogestionado [32]

Related items

Showing items related by title, author, creator and subject.

  • Thumbnail

    Hidden realities: What women do when they want to terminate an unwanted pregnancy in Bolivia 

    Bury, L; Aliaga Bruch, S; Machicao Barbery, X; Garcia Pimentel, F (2012)
    OBJECTIVE: To explore women's experience of unwanted pregnancy and induced abortion in Bolivia, where nearly all induced abortions are carried out in clandestine, unregulated, and unsafe conditions. METHODS: Qualitative ...
  • Thumbnail

    Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days 

    Fjerstad, M; Lichtenberg, ES; Trussell, J; Cleland, K; Cullins, V (2013)
    BACKGROUND: From 2001 to March 2006, Planned Parenthood Federation of America (Planned Parenthood) health centers throughout the United States provided medical abortions principally by a regimen of oral mifepristone, ...
  • Thumbnail

    Medical management of abortion, 2018 

    World Health Organization (World Health Organization, 2018)
    La atención médica relacionada con el aborto abarca el tratamiento de diversas afecciones clínicas, incluido el aborto espontáneo e inducido (embarazos tanto viables como no viables), el aborto incompleto y la muerte fetal ...

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

LoginRegister

Statistics

View Usage Statistics

Contáctenos

Contactenos via telefónica o correo electrónico

  • Teléfono: (511) 447-8668
  • Email: repo.clacai@gmail.com

Síguenos

Síguenos en Facebook y otras redes sociales.

  • Twitter
  • Facebook